| Literature DB >> 34416706 |
Nadeem R Abu-Rustum1, Catheryn M Yashar2, Kristin Bradley3, Susana M Campos4, Junzo Chino5, Hye Sook Chon6, Christina Chu7, David Cohn8, Marta Ann Crispens9, Shari Damast10, Elisabeth Diver11, Christine M Fisher12, Peter Frederick13, David K Gaffney14, Suzanne George4, Robert Giuntoli15, Ernest Han16, Brooke Howitt11, Warner K Huh17, Jayanthi Lea18, Andrea Mariani19, David Mutch20, Larissa Nekhlyudov4, Mirna Podoll9, Steven W Remmenga21, R Kevin Reynolds22, Ritu Salani23, Rachel Sisodia24, Pamela Soliman25, Edward Tanner26, Stefanie Ueda27, Renata Urban28, Stephanie L Wethington29, Emily Wyse30, Kristine Zanotti31, Nicole R McMillian32, Angela D Motter32.
Abstract
The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.Entities:
Mesh：
Year: 2021 PMID： 34416706 DOI： 10.6004/jnccn.2021.0038
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908